4th Quarter - Report

EDWARDS LIFESCIENCES, LLC for EDWARDS LIFESCIENCES LLC

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$180,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report (this page) Jan 17, 2017 $180,000 Replaced
4th Quarter - Amendment Jan 17, 2017 $180,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Federal Corporate Tax Rate Foreign Source Income Tax Deferral H.R 160, Protect Medical Innovation Act of 2015 Repatriation S. 149, Medical Device Access & Innovation Protection Act Tax Reform Taxation of Offshore Income International Tax Issues Treasury Anti-inversion Regulation Section 385

LobbyistCovered position, as disclosed
ELIZABETH RAYE KEGLER —
BARRY ROBERT LIDEN —

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 149 (114th), H.R. 160 (114th)

Health Issues HCR

H.R. 160, Protect Medical Innovation Act of 2015 H.R. 6, 21st Century Cures Act S. 149, Medical Device Access & Innovation Protection Act Senate "Innovation for Healthier Americans" Initiative Policies promoting medical innovation Medical Device User Fees Postmarket Surveilance FDA Inspection Process

LobbyistCovered position, as disclosed
ELIZABETH RAYE KEGLER —
BARRY ROBERT LIDEN —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 149 (114th), H.R. 6 (114th), H.R. 160 (114th)

Medicare/Medicaid MMM

CMS Coverage Policies For Medical Devices H.R. 6, 21st Century Cures Act Senate "Innovation for Healthier Americans" Initiative CMS Payment Policies for Medical Devices Coverage and reimbursement policy for medical devices/THV HR 5009, Ensuring Patient Access to Critical Breakthrough Products Act of 2016 S.2998, Ensuring Patient Access to Critical Breakthrough Products Act of 2016

LobbyistCovered position, as disclosed
ELIZABETH RAYE KEGLER —
BARRY ROBERT LIDEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 5009 (114th), H.R. 6 (114th), S. 2998 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.